RAPID MICRO BIOSYSTEMS, INC. (RPID) research
RAPID MICRO BIOSYSTEMS, INC.- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $0.92
- As of
RAPID MICRO BIOSYSTEMS, INC. (RPID): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-07.
As of . Source: SEC EDGAR filings for RPID. Method and limitations.
Share the RPID intelligence card
See the full RPID dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for RPID on one page. Preview it with sample data, then open it live with a free account.
Preview the RPID dossierActive signals for RPID
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +68% to RPID (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 84% of RPID (2026Q2)
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 8.8%, EPS $-0.27 vs $-0.2482 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 23.3% - EPS $-0.28 vs $-0.227 estimate
- mediumEARNINGS_MISS
Missed consensus by 23.3% - EPS $-0.28 vs $-0.227 estimate
FREE, NO ACCOUNT
Every signal on RPID, as it fires
You are seeing 5 of 6 signals recorded on RPID since 2026-05-27.
The five above landed across 4 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in RPID (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 75340L104 · 2026Q2 | $409K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 75340L104 · 2026Q2 | $367K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 75340L104 · 2026Q2 | $28K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, RPID
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
RPID against its peers
RPID's operating margin of -141.1% ranks in the 40th percentile of 23 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | RPID | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 33.6M USD | 27.5M USD | 56 | 23 |
| Gross margin | n/a | 49.8% | n/a | 19 |
| Operating margin | -141.1% | -55.8% | 40 | 23 |
| Net margin | -140.3% | -59.7% | 31 | 23 |
| Return on equity | -141.9% | -67.6% | 17 | 20 |
Peers (23): TELA, OM, COCH, MDNC, MDAI, XTNT, NNOX, SRTS, POSC, MYO, CVRX, SNWV, ZOMDF, SERA, PAVM, ELUT, QTI, LUNG, ARAY, LNSR, NSPR, HYPR, NSYS. Left out: RTGN (no annual filing), TLTFF (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (RPID: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more RPID signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to RPIDand get the insider, 13F, options, and confluence read in one view.